Ji. Merryman et al., EFFECTS OF GALLIUM NITRATE IN NUDE-MICE BEARING A CANINE ADENOCARCINOMA (CAC-8) MODEL OF HUMORAL HYPERCALCEMIA OF MALIGNANCY, Journal of bone and mineral research, 9(5), 1994, pp. 725-732
Hypercalcemic nude mice bearing a canine adenocarcinoma (CAC-8) model
of humoral hypercalcemia of malignancy (HHM) were treated daily with g
allium nitrate (60 mg/kg of elemental gallium subcutaneously (SC) on d
ay 0, followed by 20 mg/kg/day) for 5 days. Gallium nitrate significan
tly decreased (p < 0.01) serum calcium in tumor-bearing animals on day
s 2 and 5 of treatment (mean 13.7 +/- 0.7 mg/dl on day 0 versus 11.6 /- 0.3 on day 2 and 12.4 +/- 0.5 on day 5). Urinary calcium excretion
was decreased (p < 0.05) in the gallium-treated, tumor-bearing animals
(0.11 +/- 0.01 mg calcium/mg creatinine) compared with hypercalcemic
tumor-bearing mice (0.30 +/- 0.06). Both nontumor control and tumor-be
aring mice treated with gallium nitrate lost body weight during the tr
eatment period (p < 0.01). Gallium nitrate had no effect on tumor grow
th. Histomorphometric evaluation of lumbar vertebrae stained for tartr
ate-resistant acid phosphatase revealed a significant decrease (p < 0.
05) in the number of osteoclasts/mm trabecular bone and perimeter of t
rabecular bone lined by active osteoblasts (p < 0.01) in the gallium-t
reated tumor-bearing mice compared with tumor-bearing controls. Osteoc
last length (mm) was significantly increased in both the nontumor and
tumor-bearing gallium-treated animals (p < 0.05) compared with nontumo
r and tumor-bearing control mice. Serum tumor necrosis factor alpha (T
NF-alpha) levels were increased in tumor-bearing animals, but gallium
nitrate had no effect on circulating levels (not detectable in nontumo
r control mice versus 82 +/- 21 pg/ml in tumor-bearing mice and 107 +/
- 12 pg/ml in gallium-treated tumor-bearing mice). Concentrations of g
allium in bone were undetectable in untreated control mice (<0.00005 m
u g/g bone), but markedly elevated concentrations were present in gall
ium-treated mice (235 +/- 6 mu g/g bone in nontumor-bearing and 155 +/
- 18 in tumor-bearing). These results indicate that gallium nitrate de
creased osteoclastic bone resorption and serum calcium levels in a nud
e mouse model of HHM.